Table 5.
Development (N=201) | Evaluation (N=220) | |||
---|---|---|---|---|
| ||||
Majority Classifier (95% CI) | Medtex (95% CI) | Majority Classifier (95% CI) | Medtex (95% CI) | |
Basis of Diagnosis | 0.73 (0.66–0.79) | 0.96 (0.93–0.99) | 0.80 (0.74–0.85) | 0.93 (0.90–0.97) |
Histological Type | 0.17 (0.12–0.23) | 0.83 (0.78–0.88) | 0.10 (0.06–0.14) | 0.64 (0. 57–0.70) |
Histological Grade | 0.55 (0.48–0.62) | 0.94 (0.91–0.97) | 0.59 (0.52–0.65) | 0.79 (0.73–0.84) |
Primary Site | 0.11 (0.06–0.15) | 0.58 (0.51–0.65) | 0.18 (0.13–0.23) | 0.61 (0.55–0.68) |
Laterality | 0.64 (0.58–0.71) | 0.79 (0.73–0.85) | 0.61 (0.55–0.67) | 0.82 (0.77–0.87) |
Metastatic Site | 0.85 (0.80–0.90) | 0.90 (0.86–0.95) | 0.87 (0.83–0.92) | 0.90 (0.86–0.94) |
Metastatic Status | 0.85 (0.80–0.90) | 0.95 (0.91–0.98) | 0.87 (0.83–0.92) | 0.93 (0.90–0.97) |
Macro-average | 0.56 (0.49–0.62) | 0.85 (0.80–0.90) | 0.57 (0.51–0.64) | 0.80 (0.75–0.86) |
CI, confidence interval